Why Most People Regain Weight After Stopping GLP-1 Drugs
Jan 13, 2026
Continue Reading...
What the New British Medical Journal Review Really Shows
GLP-1 receptor agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) have changed obesity treatment. Many people are losing significant weight, often for the first time in years.
But a new systematic review publ...